๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Safety and Efficacy of FAP iCDC in Ischemic Cardiomyopathy
NCT07505199Ischemic Cardiomyopathy, Cell Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
30
Hangzhou
2026-05-21
Recruiting
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
NCT07413939HER2-positive Breast Cancer
Hoffmann-La Roche
Phase 2/3
650
Nanjing, Shanghai, Beijing, Bengbu, Chengdu, Fuzhou, Guangzhou, HangzhouZhejiang
2026-05-21
Recruiting
A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse
NCT07616999Schizophrenia
The University of Hong Kong
Observational
178
Hong Kong
2026-05-21
Recruiting
EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC
NCT07637448Lung Cancer Non-Small Cell Cancer (NSCLC), EGFR Activating Mutation, PD-1 Antibody
Nanfang Hospital, Southern Medical University
Phase 2
32
Guangzhou
2026-05-21
Active, closed
Phase I Clinical Trial of Adsorbed Tetanus Vaccine
NCT07598890Tetanus
Aimei Vacin BioPharm (Zhejiang) Co., Ltd.
Phase 1
80
Wuhan
2026-05-21
Not yet open
The Efficacy and Safety of Female PRP Co-incubation With Sperm During (IUI) Cycles
NCT07615634Reproductive Issues
Chinese University of Hong Kong
Not applicable
288
Hong Kong
2026-05-21
Recruiting
Safety and Preliminary Activity of BI115 in Advanced SCLC
NCT07559019Small Cell Lung Cancer (SCLC)
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
150
Chongqing
2026-05-21
Recruiting
Chinese Adults With Kidney Disease
NCT07522099Immunoglobulin A Nephropathy (IgAN), Complement 3 Glomerulopathy (C3G), IC-MPGN
ADARx Pharmaceuticals, Inc.
Phase 2
30
Shenzhen, Guiyang, Zhengzhou, Baotou, Wuxi, Yantai, Beijing, Shandong
2026-05-21
Recruiting
Low-Intensity Focused Ultrasound Targeting the Stellate Ganglion for Regulating Autonomic Nerve Function and Sleep Quality in Perioperative Patients With Cardiovascular Diseases
NCT07595068Atrial Fibrillation (AF), Cardiovascular Diseases
Renmin Hospital of Wuhan University
Not applicable
200
Huangshi, Jingzhou, Wuhan, Xiangyang, Yichang
2026-05-20
Not yet open
Selective Mediastinal Lymph Node Sampling Versus Systematic medIastinal Lymph Node Dissection After Neoadjuvant Chemoimmunotherapy for Non-small Cell Lung Cancer (SCIENCE Study)
NCT07617389Stage IIA-IIIB NSCLC, Selective Mediastinal Lymph Node Sampling, Systematic medIastinal Lymph Node Dissection
Wen-zhao ZHONG
Phase 3
358
Guangzhou
2026-05-20
Recruiting
Hearing and Brain Development Cohort in Children and Adolescents
NCT07625462Hearing Loss
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
5,000
Shanghai
2026-05-20
Recruiting
SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
NCT07549399Rectal Adenocarcinoma, High-Risk Cancer, MSS
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
204
Guangzhou
2026-05-20
Recruiting
Shortwave Intervention for Diabetic Peripheral Neuropathy.
NCT07625007Diabetic Peripheral Neuropathy
Chongqing Medical University
Not applicable
202
Chongqing
2026-05-20
Not yet open
Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer
NCT07511894Gastric Cancer
Nanfang Hospital, Southern Medical University
Phase 2
33
Guangzhou
2026-05-20
Recruiting
Effect of Lidocaine Through Gastric Tube on PONV
NCT07643298PONV
General Hospital of Ningxia Medical University
Not applicable
100
Yinchuan
2026-05-20
Recruiting
Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases
NCT07614477Minimal Change Disease (MCD), IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS)
Everest Medicines (China) Co.,Ltd.
Phase 2
45
Beijing, Tianjin
2026-05-20
Recruiting
Subthalamic Nucleus-Targeted Transcranial Temporal Interference Stimulation for Motor and Non-Motor Symptoms in Parkinson's Disease
NCT07625540Parkinson's Disease (PD)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
32
Shanghai
2026-05-20
Not yet open
Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer
NCT07596472Breast Cancer, Axillary Lymph Node Metastasis, Neoadjuvant Chemotherapy, Pathological Complete Response
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
150
Guangzhou
2026-05-20
Recruiting
Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARC
NCT07646639Rectal Cancer, Radiotherapy
The First Affiliated Hospital with Nanjing Medical University
Phase 2
122
Nanjing
2026-05-20
Not yet open
Ultrasound Assessment of Sciatic Nerve and Inferior Gluteal Artery in Diabetic Peripheral Neuropathy(DPN): Association With a Target Gene
NCT07595887Diabetic Peripheral Neuropathy (DPN)
Second Hospital of Shanxi Medical University
Observational
120
Taiyuan
2026-05-20
Not yet open
GFH375 Monotherapy and Combination Therapy as First-Line Treatment for Advanced KRAS G12D-Mutant Non-Small Cell Lung Cancer
NCT07554859NSCLC (Advanced Non-small Cell Lung Cancer)
Genfleet Therapeutics (Shanghai) Inc.
Phase 2
90
Guangzhou
2026-05-20
Not yet open
Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer
NCT07521605Rectal Cancer Patients
Guangdong Provincial People's Hospital
Phase 2
44
Guangzhou
2026-05-20
Recruiting
Ultrasound-Guided Nerve Hydrodissection for Diabetic Lower Limb Entrapment Neuropathy
NCT07625020Diabetic Peripheral Neuropathy, Entrapment Neuropathy
Chongqing Medical University
Not applicable
266
Chongqing
2026-05-20
Recruiting
IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombus
NCT07799922IRE
Tianjin Medical University Cancer Institute and Hospital
Not applicable
60
Tianjin
2026-05-20
Recruiting
Fovinaciclib Plus Aromatase Inhibitors and Dual HER2 Blockade in a Response-Adapted Neoadjuvant Strategy for HR-Positive/HER2-Positive Early Breast Cancer
NCT07616427HR+/HER2+ Early Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
100
Nanjing, Hangzhou, Ningbo
2026-05-20
Recruiting
R-PMDT Regimen in Newly Diagnosed PCNSL
NCT07604987Primary Central Nervous System (CNS) Lymphoma
Zou Dehui
Phase 2
33
Tianjin
2026-05-20
Active, closed
Spatial MSC Index for Predicting Anti-PD-1 Efficacy in Esophageal Cancer
NCT07745322Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms
Peking University Cancer Hospital & Institute
Observational
270
Beijing
2026-05-20
Recruiting
A Study of SKB571 in Participants With Gastrointestinal Tumors
NCT07564466Gastrointestinal Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
120
Chongqing, Fuzhou, Xiamen, Guangzhou, Nanning, Shijiazhuang, Harbin, Luoyang
2026-05-20
Recruiting
Randomized Controlled Trial of Multi-Patient CT-Derived Digital Twin Anatomical Variability Training to Shorten the Clinical Learning Curve for Bronchoscopy
NCT07718451Bronchoscopy, Learning Curves and Outcomes of Simulation-based Training, Learning Curve
Gang Hou
Not applicable
110
Beijing
2026-05-20
Recruiting
A Clinical Study of HRS-5765 in Healthy Participants
NCT07551167Heart Failure
Chengdu Suncadia Medicine Co., Ltd.
Phase 1
74
Beijing
2026-05-20
Recruiting
IRE After Chemotherapy for Locally Advanced Pancreatic Cancer
NCT07799935IRE
Tianjin Medical University Cancer Institute and Hospital
Not applicable
60
Tianjin
2026-05-20
Not yet open
A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer
NCT07585279Metastatic Colorectal Cancer (CRC), Liposomal Irinotecan, Second-Line
Hebei Medical University Fourth Hospital
Phase 2/3
408
Shijiazhuang
2026-05-20
Recruiting
Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus
NCT07483359Hepatocellular Carcinoma (HCC), Portal Vein Tumor Thrombus
First Hospital of China Medical University
Phase 2
38
Shenyang
2026-05-20
Recruiting
Study on iTBS Regulating the Reward Circuit Function to Improve Anhedonia in Depression
NCT07813169Major Depression, Anhedonia, Melancholic Depression, Theta Burst Stimulation
Guo Wenbin
Not applicable
60
Changsha
2026-05-19
Recruiting
Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP)
NCT07594301Acute Ischemic Stroke, Endovascular Thrombectomy, Minocycline, Posterior Circulation
Xiang Luo
Phase 2/3
234
Wuhan
2026-05-19
Recruiting
CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
NCT07612774Coronary, Coronary Artery Disease
West China Hospital
Phase 4
233
Chengdu
2026-05-19
Recruiting
Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting Conditions
NCT07606105Healthy Adult
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1
70
Jinan
2026-05-19
Recruiting
A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC
NCT07547553Advanced or Unresectable Hepatocellular Carcinoma (HCC)
Huahui Health
Phase 1/2
30
Bengbu, Hefei, Beijing, Fuzhou, Guangzhou, Nanning, Harbin, Zhengzhou
2026-05-19
Not yet open
Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk Triple-Negative Breast Cancer Without BRCA Mutations
NCT07628504Adjuvant Drug Therapy
Fudan University
Phase 3
420
Shanghai
2026-05-18
Recruiting
Sub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo
NCT07612722NSCLC
Wen-zhao ZHONG
Not applicable
585
Guangzhou
2026-05-18
Recruiting
Electrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation
NCT07608120Colonoscopy, Bowel Preparation Solutions, Colorectal Cancer Screening
Nanfang Hospital, Southern Medical University
Not applicable
405
Guangzhou
2026-05-18
Active, closed
A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants
NCT07577479Healthy Participants Study
Shanghai Argo Biopharmaceutical Co., Ltd.
Phase 1
24
Shanghai
2026-05-18
Recruiting
A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome
NCT07406932Antisynthetase Syndrome, Interstitial Lung Disease (ILD)
China-Japan Friendship Hospital
Not applicable
80
Beijing
2026-05-18
Recruiting
Whole-life Investigation of Lishui Longevity
NCT07592962Ischemic Stroke, Chronic Disease, Cardiovascular
The Fifth Affiliated Hospital of Wenzhou Medical University & Lishui Central Hospital
Observational
4,500
Lishui
2026-05-18
Recruiting
A Clinical Trial Evaluating the Monkeypox Recombinant Protein Vaccine
NCT07495202Health Volunteer
Shanghai JunTop Biosciences Co., LTD
Phase 1
180
Shenzhen
2026-05-18
Recruiting
Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China
NCT07604688Intracranial Dural Arteriovenous Fistula
Xuanwu Hospital, Beijing
Observational
10,050
Beijing
2026-05-18
Recruiting
Efficacy and Safety of Anlotinib Combined With Bemocizumab for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma(ESCC)
NCT07627347ESCC
Nanfang Hospital, Southern Medical University
Not applicable
25
Guangzhou
2026-05-18
Recruiting
A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
NCT07632573Ulcerative Colitis (UC), Ulcerative Colitis (Disorder), Ulcerative Colitis Acute, IBD (Inflammatory Bowel Disease)
Benethera (Shaoxing) Biotechnology Co., Ltd.
Phase 1
68
Hangzhou
2026-05-18
Not yet open
Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction
NCT07586865Acute Myocardial Infarction (AMI), Acute Myocardial Infarction of Anterior Wall, Acute Myocardial Infarction With ST Elevation, Acute Myocardial Infarction of Left Ventricle
Beijing Northland Biotech. Co., Ltd.
Phase 2
189
Beijing
2026-05-18
Active, closed
A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLC
NCT07556549Non-Small Cell Lung Cancer ALK-positive
Pfizer
Observational
50
Beijing
2026-05-18
Recruiting
A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer
NCT07649928Pancreatic Cancer
Ruijin Hospital
Phase EARLY_PHASE1
24
Shanghai
2026-05-18
Recruiting
A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer.
NCT07483970High Risk Non-muscle Invasive Bladder Cancer
Jecho Biopharmaceuticals Co., Ltd.
Phase 1
18
Chengdu
2026-05-18
Recruiting
A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis
NCT07693738AD
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 1
96
Shanghai
2026-05-18
Recruiting
A Study of TAK-755 in Adults With Acute Ischemic Stroke
NCT07392450Acute Ischemic Stroke
Takeda
Phase 2
222
Beijing, Nanyang, Xuzhou, Jinan, Liaocheng, Linyi, Datong, Linfen
2026-05-17
Not yet open
A Study About Remote and Local Liver Surgery
NCT07524699Liver Diseases
Tongji Hospital
Not applicable
148
Wuhan
2026-05-16
Not yet open
HERO-UTUC: Intravesical RC48 After RNU for HER2+ UTUC
NCT07591805Upper Urinary Tract Urothelial Carcinoma
RenJi Hospital
Phase 2
49
Shanghai
2026-05-16
Recruiting
Adaptive DBS for PD
NCT07635823Parkinson Disease(PD)
Beijing Pins Medical Co., Ltd
Not applicable
60
Hefei, Beijing, Guangzhou, Changsha, Nanjing, Jinan, Chengdu
2026-05-16
Not yet open
The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.
NCT07592754Neuromyelitis Optica Spectrum Disease (NMOSD)
Chinese PLA General Hospital
Phase EARLY_PHASE1
18
Beijing
2026-05-15
Not yet open
Clinical Efficacy Evaluation of Chaizhi Hewei Decoction in the Treatment of Non-Erosive Reflux Disease With Liver-Stomach Disharmony Syndrome
NCT07518420Non-erosive Reflux Disease (NERD)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Not applicable
66
Beijing
2026-05-15
Recruiting
SIM0613 in Participants With Advanced Solid Tumors
NCT07618260Advanced Solid Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
294
Tianjin
2026-05-15
Not yet open
A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)
NCT07593144Advanced Solid Tumors
Foresight Therapeutics (Hefei) Co., Ltd.
Phase 1
156
Hefei, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanchang, Changchun
2026-05-15
Not yet open
Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma
NCT07554482Extranodal NK/T-cell Lymphoma
Beijing Tongren Hospital
Phase 2
34
Beijing
2026-05-15
Not yet open
Treatment of Truncated ALK-positive Bone Cancer Using Crizotinib (Xalkori) or Alectinib (Alecensa)
NCT07560410Bone Cancer
China Medical University Hospital
Phase 1/2
10
2026-05-15
Not yet open
Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib
NCT07486648Lung Cancer (NSCLC), Lung Cancer (Non-Small Cell), Advanced Non-small-cell Lung Cancer
Shanxi Province Cancer Hospital
Phase 1/2
53
Beijing, Taiyuan
2026-05-15
Recruiting
Efficacy and Safety of Bronchoscopic Local Amikacin Instillation for Acute Exacerbations of Bronchiectasis in Adults: A Multicenter, Blinded, Randomized Controlled Trial
NCT07813299Bronchiectasis With Acute Exacerbation
First Affiliated Hospital of Ningbo University
Not applicable
186
Ningbo
2026-05-15
Recruiting
The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer
NCT07596654Esophageal Carcinoma, Limited-Stage Small Cell Esophageal Carcinoma
yi shen
Observational
4
Nanjing
2026-05-15
Not yet open
A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy Participants
NCT07559240Overweight, Obese
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
30
Beijing
2026-05-15
Recruiting
Research and Application of an AI Agent-Based MBBS Course Assistant
NCT07752160an Intelligent Teaching Agent for the "Epidemiology" Course of the MBBS Program, Students' Critical Thinking, Practical Ability and Learning Outcomes
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Not applicable
60
Yiwu
2026-05-15
Recruiting
Comparison of Speaking Valve Trial and Capping Trial for Tracheostomy Decannulation in Stroke Patients
NCT07435727Stroke
Hongying Jiang, MD
Not applicable
120
Beijing
2026-05-15
Recruiting
HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)
NCT07594340Hepatocellular Carcinoma
Binkui Li
Phase 3
300
Guangzhou
2026-05-15
Not yet open
Gait Retraining for Runners With Patellofemoral Pain
NCT07557797Patellofemoral Pain, PFP
Beijing Sport University
Not applicable
44
Beijing
2026-05-15
By invitation
Large-scale Models of Esophageal Cancer and Related Research
NCT07642401Esophageal Cancer
The First Affiliated Hospital of Henan University of Science and Technology
Observational
12,000
Anyang, Luoyang, Nanyang
2026-05-15
Not yet open
Safety and Efficacy of High-Channel Implanted BCI for Motor Function Improvement in Tetraplegia Patients
NCT07457645Tetraplegic Motor Dysfunction Following Brainstem or Spinal Cord Injury
Shanghai Zhongshan Hospital
Not applicable
10
Shanghai
2026-05-15
Recruiting
Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer
NCT07551050TNBC - Triple-Negative Breast Cancer
Fudan University
Observational
300
Shanghai
2026-05-15
Not yet open
Effect of Finerenone on Myocardial Fibrosis and Cardiac Function in HFmrEF/HFpEF Patients
NCT07583173Heart Failure
China National Center for Cardiovascular Diseases
Phase 4
104
Beijing
2026-05-15
Not yet open
Study of IBI3016 in People With Mild or Moderate Hypertension Patients
NCT07556796Hypertension
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
30
Beijing
2026-05-15
Recruiting
Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment Elevation Myocardial Infarction
NCT07587294Acute ST-segment Elevation Myocardial Infarction (Patients Undergoing Emergency PCI)
Renmin Hospital of Wuhan University
Not applicable
100
Huangshi, Jingzhou, Shiyan, Wuhan, Xiangyang
2026-05-15
Not yet open
The Effect of Intraoperative Esketamine Infusion on Pruritus in Elderly Surgical Patients
NCT07597486Senile Pruritus
Tianjin Medical University General Hospital
Not applicable
200
Tianjin
2026-05-15
Not yet open
Effects of Cofrogliptin on Beta-Cell Function in LADA Patients
NCT07460336Latent Autoimmune Diabetes in Adults (LADA)
Second Xiangya Hospital of Central South University
Not applicable
84
Changsha
2026-05-15
Recruiting
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
NCT07607275Hypertension, Essential (Primary) Hypertension
Beijing Anzhen Hospital
Phase 4
350
Beijing, Chongqing, Dalian, Hohhot, Longyan, Luohe, Nanchang, Nanjing
2026-05-15
Recruiting
Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD
NCT07632677Type 2 Diabetes Mellitus (T2DM), MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction-associated Fatty Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
10,000
Bengbu, Hefei, Wuhu, Guangzhou, Shenzhen, Nanning, Zunyi, Haikou
2026-05-15
Not yet open
Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors
NCT07558200Solid Tumors, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 1
138
Shanghai
2026-05-15
Active, closed
LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia
NCT07350486Hypertension, Diabetes, Dyslipidemia
First Hospital of China Medical University
Not applicable
6,800
Cangzhou, Suzhou, Panjin, Shenyang, Jinzhou, Tianjin
2026-05-14
Recruiting
Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion
NCT07519044Stroke, Acute Ischemic Stroke
Xuanwu Hospital, Beijing
Phase 4
868
Beijing, Shandong
2026-05-14
Recruiting
Levetiracetam for Seizure Prevention After Brain Tumor Surgery
NCT07239115Postoperative Seizures After Brain Tumor Surgery
Beijing Tiantan Hospital
Phase 3
558
Beijing
2026-05-14
Recruiting
Impact of Allometric Pacing Rate on Ventricular Diastolic Function and Cerebral Blood Flow in Hypertensive Patients With Sinus Node Dysfunction
NCT07589452Bradycardia
Medtronic Cardiac Rhythm and Heart Failure
Not applicable
70
Taiyuan
2026-05-14
Not yet open
PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC
NCT07630363Advanced Renal Cell Carcinoma (RCC), PTC, Atorvastatin, Targeted Therapy Combined With Immunotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2
40
Beijing
2026-05-14
Recruiting
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
NCT07392892Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma, Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, Esophageal Adenocarcinoma
Pfizer
Phase 2/3
840
Shanghai
2026-05-14
Recruiting
Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection
NCT07519330Chronic Hepatitis B Virus Infection
Huahui Health
Phase 2
45
Chongqing
2026-05-14
Not yet open
A Study to Evaluate the Safety, PK, and Immunogenicity of Recombinant Human Hyaluronidase in Healthy Subjects
NCT07484893Healthy Adult Male
Shanghai Henlius Biotech
Phase 1
24
Hefei
2026-05-14
Recruiting
Association Between Screening Behaviors and Lung Cancer Spectrum
NCT07626177Lung Cancer
Fudan University
Observational
5,390
Shanghai
2026-05-14
Recruiting
Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.
NCT07582796Respiratory Syncytial Virus Infections
Ab&B Bio-tech Co., Ltd.JS
Phase 1/2
470
Zigong
2026-05-14
Not yet open
LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure
NCT07602322Large B-cell Lymphoma
Ruijin Hospital
Phase 2
60
Shanghai
2026-05-14
Active, closed
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions
NCT07645209Liver Cancer
Harbin Medical University
Observational
1,000
Harbin
2026-05-13
Rows per page Showing 2201–2300 of 19052
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=23

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.